Norepinephrine-dopamine releasing agent
A norepinephrine-dopamine releasing agent (NDRA) is a type of drug which induces the release of norepinephrine (and epinephrine) and dopamine in the body and/or brain.
Examples of NDRAs include phenethylamine, tyramine, amphetamine, methamphetamine, lisdexamfetamine, cathinone, methcathinone, propylhexedrine, phenmetrazine, pemoline, 4-methylaminorex, and benzylpiperazine.
A closely related type of drug is a norepinephrine-dopamine reuptake inhibitor (NDRI).
See also
References
|
---|
|
Reuptake inhibitors | DAT (DRIs) | |
---|
| NET (NRIs) | | | | | | | | | | | | |
- Others: Antihistamines (e.g., brompheniramine, chlorphenamine, pheniramine, tripelennamine)
- Arylcyclohexylamines (e.g., ketamine, phencyclidine)
- CP-39,332
- Dopexamine
- EXP-561
- Fezolamine
- Ginkgo biloba
- Indeloxazine
- Loxapine
- Nefazodone
- Nefopam
- Opioids (e.g., methadone, pethidine (meperidine), tapentadol, tramadol, levorphanol)
- Pridefine
- Tedatioxetine
- Teniloxazine
- Tofenacin
- Tropanes (e.g., cocaine)
- Ziprasidone
|
|
---|
| SERT (SRIs) | | | | | | | | |
- Others: A-80426
- Amoxapine
- Antihistamines (e.g., brompheniramine, chlorphenamine, dimenhydrinate, diphenhydramine, mepyramine (pyrilamine), pheniramine, tripelennamine)
- Arylcyclohexylamines (e.g., esketamine, ketamine, phencyclidine)
- CP-39332
- Cyclobenzaprine
- Dextromethorphan
- Dextrorphan
- Efavirenz
- Etoperidone
- EXP-561
- Fezolamine
- Litoxetine
- LY-393558
- Loxapine
- Lubazodone
- Medifoxamine
- Mesembrine
- Mifepristone
- MIN-117 (WF-516)
- N-Me-5-HT
- Opioids (e.g., dextropropoxyphene, methadone, pethidine (meperidine), levorphanol)
- PIM-35
- Pridefine
- Roxindole
- SB-649915
- TGBA01AD
- Tofenacin
- Trazodone
- Tropanes (e.g., cocaine)
- Vortioxetine
- Ziprasidone
|
|
---|
| VMATs | |
---|
|
---|
|
Releasing agents | |
---|
|
Others | |
---|
|
See also: Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins |
|
---|
|
TAAR1 | |
---|
|
TAAR2 | |
---|
|
TAAR5 | |
---|
|
‡References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and antagonists, see TAAR for references. |